Shenzhen TargetRx, Inc. Tech Stack

Clinical-stage biotech developing AI-powered targeted cancer therapies

Pharmaceutical Manufacturing shenzhen, Guangdong 51–200 employees Founded 2014 Privately Held

TargetRx is a clinical-stage pharmaceutical R&D company using machine learning (PyTorch, TensorFlow, XGBoost) and computational biology (Cryo-EM, UniProt) to accelerate small-molecule drug discovery for resistant cancers. The tech stack and active projects reveal a company actively building internal AI-driven platforms for candidate identification while managing the parallel complexity of multi-national clinical trials, GMP compliance, and manufacturing scale-up—a hiring mix weighted toward research (8 roles) and biostatistics leadership underscores their computational intensity.

Tech Stack 23 technologies

Core StackPython PyTorch TensorFlow scikit-learn SAP S/4HANA SAS Cisco Ansible Terraform Linux Power BI Microsoft Office Bash HPC XGBoost UniProt Cryo-EM SAP R/3 R CDISC Cisco ISE Cisco Unified Communications Manager Windows

What Shenzhen TargetRx, Inc. Is Building

◆Challenges

Ensuring gmp compliance
Compliance with laws and regulations
Budget planning and target deviations
Ensuring profitability in assigned region
Business process effectiveness
Ai adoption in drug discovery
Rapid discovery of clinical candidates
Supplier audit coordination
Risk management in api production
Reducing tax costs

▲Active Projects

Deployment of the sales strategy
Project implementation prioritization
Budget planning and fc planning
R&d quality system development
Clinical trial statistical strategy development
Develop ai models for drug discovery
Build internal ai-driven drug discovery platform
Implement ai in drug discovery
New drug clinical submission
Clinical study protocol development

Hiring Activity

Decelerating20 roles · 3 in 30d

Department

Research

Sales

Engineering

Manufacturing

Ops

Data

Finance

Healthcare

Seniority

Senior

Mid

Manager

Junior

Lead

Notable leadership hires: Quality Lead, Biostatistics Lead

Company intelligence

Find more companies like Shenzhen TargetRx, Inc. by tech stack, pain points and active projects

Get started free

About Shenzhen TargetRx, Inc.

TargetRx was founded in 2014 and operates as a clinical-stage biopharmaceutical company based in Shenzhen, Guangdong. The company focuses on developing next-generation targeted therapies for cancer patients with resistance to current treatments, leveraging proprietary small-molecule drug discovery platforms. TargetRx holds over 170 patents across China, the US, Europe, Japan, and other jurisdictions. Several compounds are currently in multi-national clinical trials at various stages. The organization runs approximately 51–200 employees across research, manufacturing, quality, biostatistics, and commercial functions, with active hiring concentrated in China.

Headquartersshenzhen, Guangdong

Company Size51–200 employees

Founded2014

Hiring MarketsChina

Frequently Asked Questions

What is TargetRx's tech stack?

TargetRx uses PyTorch, TensorFlow, XGBoost, and scikit-learn for ML; Cryo-EM and UniProt for structural biology; SAP S/4HANA and SAP R/3 for enterprise operations; SAS and R for statistical analysis; Power BI for analytics; and Cisco infrastructure.

What is TargetRx working on?

Primary projects include building internal AI-driven drug discovery platforms, developing clinical trial statistical strategies, R&D quality system development, and advancing new drug clinical submissions across multi-national trials.